Stem cell therapy: a future treatment of stress urinary incontinence
- PMID: 21207335
- DOI: 10.1055/s-0030-1268705
Stem cell therapy: a future treatment of stress urinary incontinence
Abstract
The main urinary continence mechanism in human is the striated muscle rhabdosphincter that forms a ring around the mid-urethra. Cellular therapy and the use of stem cells transplanted into the site of the rhabdosphincter in a setting of stress urinary incontinence (SUI) may augment sphincter regeneration. Implanted cells may also release trophic factors promoting muscle and nerve integration into this muscle. We review the use of cellular therapy for SUI and our experience with the development of muscle-derived stem cells.
Comment in
-
Re: The clinical relevance of cell-based therapy for the treatment of stress urinary incontinence.J Urol. 2012 Dec;188(6):2303-5. doi: 10.1016/j.juro.2012.08.159. Epub 2012 Oct 22. J Urol. 2012. PMID: 23141254 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical